Beyond Dopamine Receptor Antagonism: New Targets for Schizophrenia Treatment and Prevention

Treatment of schizophrenia (SCZ) historically relies on the use of antipsychotic drugs to treat psychosis, with all of the currently available antipsychotics acting through the antagonism of dopamine D2 receptors. Although antipsychotics reduce psychotic symptoms in many patients, they induce numero...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomes, Felipe V., Grace, Anthony A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123139/
https://www.ncbi.nlm.nih.gov/pubmed/33922888
http://dx.doi.org/10.3390/ijms22094467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123139/
https://www.ncbi.nlm.nih.gov/pubmed/33922888
http://dx.doi.org/10.3390/ijms22094467

Ejemplares similares